🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementFAERS pharmacovigilance data for semaglutide — anyone have experience? Page 5

FAERS pharmacovigilance data for semaglutide — anyone have experience?

bri_stats Thu, Mar 21, 2024 at 2:29 PM 36 replies 2,800 viewsPage 5 of 8
denise_HTX
Member
145
678
Jan 2025
Houston, TX
Apr 2, 2024 at 11:42 AM#21

One thing that is still open after james_edin’s answer:

What did you change at the same time, and can you separate the two now?

8 6sarah.morrison, NeuroNate, JessicaH_TX and 5 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Apr 4, 2024 at 4:16 PM#22
SallyK_inj said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

I read this differently from SallyK_inj, on substance rather than tone. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

I would rather be corrected than agreed with, if it comes to it.

9 7alex_tucson, kevin_tulsa, Dr.PainCLE and 6 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Apr 6, 2024 at 8:49 PM#23
SallyK_inj said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

Happy to go further on any of that.

10 8tommy_boulder, hyun_seoul, jim_asheville and 7 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Apr 9, 2024 at 1:21 AM#24
SallyK_inj said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Thank you for spelling out the reasoning rather than just the conclusion. Printing the relevant bit and taking it with me.

11 9PharmacoVig_BOS, SurmountFan_IN, PeptideChemSF and 8 others
Reply Quote Save Share Report
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Apr 11, 2024 at 5:52 AM#25

Adding the clinical framing, because it changes how the question reads. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Last edited: Apr 11, 2024 at 6:52 AM
12 10jason_sac26, chris_chi24, tampaLisa73 and 9 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register